FMC (FMC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
3 Mar, 2026Executive summary
The annual meeting will be held virtually on April 28, 2026, with voting on key governance and compensation matters.
The agenda includes director elections, auditor ratification, executive compensation, amendments to governance documents, and a new incentive stock plan.
Shareholder engagement and feedback have influenced recent changes to executive compensation and governance proposals.
Voting matters and shareholder proposals
Election of ten directors for one-year terms.
Ratification of KPMG LLP as independent auditor for 2026.
Advisory vote on executive compensation (say-on-pay).
Amendments to eliminate supermajority voting provisions and standards for business combinations.
Amendments to allow shareholders with 25% ownership to call special meetings.
Miscellaneous amendments to modernize the Certificate of Incorporation.
Approval of the 2026 Incentive Stock Plan.
Board of directors and corporate governance
Board will be reduced to 10 members post-meeting, with a focus on diversity, independence, and relevant industry experience.
Five standing committees: Audit, Compensation and Human Capital, Nominating and Corporate Governance, Executive, and Sustainability.
All non-employee directors are independent; director compensation is benchmarked and reviewed annually.
Shareholder nomination and proxy access provisions are in place.
Directors are subject to stock ownership guidelines and annual performance reviews.
Latest events from FMC
- Key governance, compensation, and shareholder rights reforms headline the 2026 annual meeting.FMC
Proxy Filing13 Mar 2026 - Key votes include director elections, say-on-pay, and expanded shareholder rights proposals.FMC
Proxy Filing13 Mar 2026 - Operational overhaul, asset sales, and licensing drive transformation amid strategic review.FMC
Bank of America 2026 Global Agriculture and Materials Conference26 Feb 2026 - 2025 losses deepen on price pressure and impairment; 2026 outlook cautious amid strategic review.FMC
Q4 20255 Feb 2026 - Recovery underway, new products and cost actions position for strong growth through 2025.FMC
Wolfe Research Materials of the Future Conference3 Feb 2026 - Q2 net income surged on tax benefit; full-year guidance trimmed, but H2 rebound expected.FMC
Q2 20242 Feb 2026 - Leadership change, cost savings, and new products set the stage for growth and recovery.FMC
Wells Fargo 2024 Industrials Conference1 Feb 2026 - New product launches and a shift to formulations drive growth as markets normalize.FMC
Jefferies Global Industrial Conference22 Jan 2026 - Q3 revenue up 9% to $1.07B; restructuring and GSS sale drive improved outlook.FMC
Q3 202417 Jan 2026